drugset / Trial / NCT06036927
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial to evaluate the efficacy, safety and pharmacokinetics of TQC2731 injection in the treatment of Chronic Sinusitis with Nasal Polyps.
Timeline
- Start
- 2023-12-08
- Primary completion
- 2025-02-05
- Completion
- 2025-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQC2731 | Monoclonal antibody | 210 mg | — |
| Subject | TQC2731 | Monoclonal antibody | 420 mg | — |